Athersys (ATHX) Stock Analysis

What Athersys does

Athersys, Inc. operates as a biotechnology enterprise specializing in the research and development of regenerative medicine. Its clinical initiatives are directed towards addressing a range of health issues, including neurological disorders, cardiovascular diseases, inflammatory and immune system conditions, and pulmonary ailments. The company's primary therapeutic asset is MultiStem, an allogeneic stem cell treatment, which is currently in Phase III clinical trials. MultiStem is being evaluated for its efficacy in treating neurological damage subsequent to an ischemic stroke, acute respiratory distress syndrome, trauma-related complications, and in providing support for hematopoietic stem cell transplants, among other applications. Furthermore, Athersys is advancing MultiStem for veterinary purposes, aiming to foster tissue regeneration and recovery in animals afflicted with severe, unmet medical needs. The firm maintains key partnerships, including a collaboration with Healios K.K. to develop and commercialize MultiStem for ischemic stroke, ARDS, ophthalmic conditions, and diseases affecting the liver, kidneys, pancreas, and intestines. It also partners with the University of Minnesota to further develop the MultiStem cell therapy platform. Athersys, Inc. was founded in 1995 and its headquarters are located in Cleveland, Ohio.

Key metrics

ETFs linked to ATHX

Broad-market and Healthcare sector ETFs an investor holding Athersys is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ATHX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Athersys?

Athersys trades under the ticker ATHX on NASDAQ.

Which exchange is ATHX listed on?

ATHX is listed on NASDAQ.

What sector does Athersys operate in?

Athersys is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ATHX in a portfolio?

PortView shows ATHX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.